Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320151 · ClinicalTrials.gov registry record
Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 3,087
- Enrollment target
NCT00320151 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 3,087 participants.
The verdict
NCT00320151 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 3,087 participants
- Enrollment target
Study Summary
This protocol is designed to gather a small amount of blood from patients seen in the New York Presbyterian Hospital-Weill Cornell Medical Center Pulmonary, Critical Care unit, and 5 West floor (Pulmonary Floor) for clinical care associated with chronic lung disease. This protocol will also survey medical records of patients with chronic lung disease, in order to study the clinical characteristics of these individuals. Investigators aim to understand the genetics of chronic lung diseases, and will use the serum and DNA from this blood to perform various genotyping studies such as such as genomic/gene expression studies of individuals with chronic lung diseases
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,087 participants |
| Start Date | 2006-04 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00320151
The ClinicalTrials.gov registry entry for NCT00320151 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,087 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00320151 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00320151 about?
NCT00320151 is a clinical study titled "Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases". This protocol is designed to gather a small amount of blood from patients seen in the New York Presbyterian Hospital-Weill Cornell Medical Center Pulmonary, Critical Care unit, and 5 West floor (Pulmonary Floor) for clinical care associated with chronic lung disease. This protocol will also survey m...
What is the current status of trial NCT00320151?
This trial is currently completed. The enrollment target is 3,087 participants. The study started on 2006-04. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT00320151?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.